Other languages Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Market Closed - Nyse Other stock markets 16:00:02 2024-05-01 EDT			5-day change	1st Jan Change
3.2 ^USD	+7.02%		+20.30%	+111.92%

04-17	RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	MT
04-10	Nuvation Bio Closes Acquisition of AnHeart Therapeutics	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuvation Bio Closes Acquisition of AnHeart Therapeutics	04-10
Nuvation Bio Inc. Announces Appointment of Directors	04-10
Nuvation Bio Inc. completed the acquisition of AnHeart Therapeutics Ltd	04-08
Nuvation Bio Inc. Appoints Colleen Sjogren as Chief Commercial Officer	03-28
Nuvation Bio Shares Jump After Jefferies Upgrade	03-27
Top Premarket Gainers	03-27
Nuvation Bio Agrees to Acquire AnHeart Therapeutics in All-Stock Deal -- Shares Fall	03-25
Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment	03-14
Nuvation Bio Inc. Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors	03-14
Nuvation Bio Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29
Nuvation Bio Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29
Nuvation Bio Receives US FDA Clearance for Investigational New Drug Application for NUV-1511	01-08
Nuvation Bio Inc. Announces Appointment of Robert Mashal to Its Board of Directors	01-08
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors	01-08
Nuvation Bio Inc. Announces Resignation of Oleg Nodelman from Board of Directors	12-14
Nuvation Bio Inc. Appoints Moses Makunje as Principal Accounting Officer and Principal Financial Officer	11-27
Nuvation Bio Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02
Nuvation Bio Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Nuvation Bio Inc. Announces Formation of Oncology-Focused Scientific Advisory Board	23-06-01
Nuvation Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Other languages

Filters